Abstract:Postprandial, or meal-related, symptoms, such as abdominal pain, early satiation, fullness or bloating, are often reported by patients with disorders of gut-brain interaction, including functional dyspepsia (FD) or irritable bowel syndrome (IBS). We propose that postprandial symptoms arise via a distinct pathophysiological process. A physiological or psychological insult, for example, acute enteric infection, leads to loss of tolerance to a previously tolerated oral food antigen. This enables interaction of both the microbiota and the food antigen itself with the immune system, causing a localised immunological response, with activation of eosinophils and mast cells, and release of inflammatory mediators, including histamine and cytokines. These have more widespread systemic effects, including triggering nociceptive nerves and altering mood. Dietary interventions, including a diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols, elimination of potential food antigens or gluten, IgG food sensitivity diets or salicylate restriction may benefit some patients with IBS or FD. This could be because the restriction of these foods or dietary components modulates this pathophysiological process. Similarly, drugs including proton pump inhibitors, histamine-receptor antagonists, mast cell stabilisers or even tricyclic or tetracyclic antidepressants, which have anti-histaminergic actions, all of which are potential treatments for FD and IBS, act on one or more of these mechanisms. It seems unlikely that food antigens driving intestinal immune activation are the entire explanation for postprandial symptoms in FD and IBS. In others, fermentation of intestinal carbohydrates, with gas release altering reflex responses, adverse reactions to food chemicals, central mechanisms or nocebo effects may dominate. However, if the concept that postprandial symptoms arise from food antigens driving an immune response in the gastrointestinal tract in a subset of patients is correct, it is paradigm-shifting, because if the choice of treatment were based on one or more of these therapeutic targets, patient outcomes may be improved.

Emergence of SCCmec type III with variable antimicrobial resistance profiles and spa types among methicillin-resistant Staphylococcus aureus isolated from healthcare- and community-acquired infections in the west of Iran.

Quality of life, survivorship, and psychosocial adjustment of young women with breast cancer after breast-conserving surgery and radiation therapy.

Acute hepatitis B in New Zealand.

Nutrition and Disorders of Gut–Brain Interaction

Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target

Mechanisms of Food-Induced Symptom Induction and Dietary Management in Functional Dyspepsia

Mechanisms by which gut microorganisms influence food sensitivities

Multispectral camera and radiative transfer equation used to depict Leonardo's sfumato in Mona Lisa.

Patient-Reported Outcomes in Disorders of Gut–Brain Interaction

Advances in Brain–Gut–Microbiome Interactions: A Comprehensive Update on Signaling Mechanisms, Disorders, and Therapeutic Implications

Taste receptors of the gut: emerging roles in health and disease

Pathways in gut-brain communication: Evidence for distinct gut-to-brain and brain-to-gut syndromes

VP7 and VP4 Sequence Analyses of Rotavirus Strains From Italian Children With Viraemia and Acute Diarrhoea

The role of the gut microbiome in disorders of gut–brain interaction

Sensation of dietary nutrients by gut taste receptors and its mechanisms

Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease

A multi-modal approach to assessing recovery in youth athletes following concussion.

Methodological advances in gastrointestinal tract physiology measurements: relevance to nutritional studies

Interactions between the microbiota and enteric nervous system during gut-brain disorders

Irritable bowel syndrome: treatment based on pathophysiology and biomarkers

Duodenal inflammation: an emerging target for functional dyspepsia?